Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04313985 · ClinicalTrials.gov registry record · NA
Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04313985: Clinical Trial NA study, sponsored by Stanford University.
NCT04313985 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04313985, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.
Interventions
- DEVICE Tennant Biomodulator-Pro™ Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04313985
The ClinicalTrials.gov registry entry for NCT04313985 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tennant Biomodulator-Pro™ Device is the first listed.
NCT04313985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04313985 about?
NCT04313985 is a clinical study titled "Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD". The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.
What is the current status of trial NCT04313985?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-08-01. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04313985?
The interventions under investigation include: Tennant Biomodulator-Pro™ Device (DEVICE).
Who is sponsoring clinical trial NCT04313985?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.